EP3805243
ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2A FOR THE TREATMENT OF HEART FAILURE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.10.2019EP published:
15.11.2023EP application number:
19202257.2
EPO information:
European Patent Register
Max expiry date:
8.10.2039
Title in English:
ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2A FOR THE TREATMENT OF HEART FAILURELanguage of the patent:
English
Timeline
Today
9.10.2019EP application
15.11.2023EP Publication
Owner
Name:
Windtree Therapeutics, Inc.Address:
2600 Kelly Road, Suite 100, Warrington, PA 18976-3622, US
Inventor
Name:
CERRI, AlbertoAddress:
deceased, IT
Name:
FERRARI, PatriziaAddress:
21100 Varese, IT
Name:
FERRANDI, MaraAddress:
20100 Milano, IT
Name:
BARASSI, PaoloAddress:
21010 Castelvaccana (VA), IT
Name:
BIANCHI, GiuseppeAddress:
20133 Milano, IT
Name:
HSU, Shin-CheAddress:
TAIWAN, CN
Name:
PERI, FrancescoAddress:
20141 Milano, IT
Name:
ZAZA, AntonioAddress:
20144 Milano, IT
Name:
ROCCHETTI, MarcellaAddress:
20861 Brugherio (MB), IT
Name:
LURAGHI, AndreaAddress:
20023 Cerro Maggiore, IT
Name:
TORRE, EleonoraAddress:
20832 Desio (MB), IT
Name:
RONCHI, CarlottaAddress:
20159 Milano, IT
Classification
Categories:
C07J 1/00, C07J 41/00, C07J 43/00, A61K 31/566, A61K 31/58, A61P 9/04, C07J 21/00, C07J 51/00